Colforsin dapropate

Drug Profile

Colforsin dapropate

Alternative Names: Adehl; Colforsin daropate hydrochloride; NKH 477

Latest Information Update: 27 Aug 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nippon Kayaku
  • Class Diterpenes; Heart failure therapies
  • Mechanism of Action Adenylate cyclase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Acute heart failure
  • Discontinued Asthma

Most Recent Events

  • 27 Aug 2007 Discontinued - Preclinical for Asthma in Japan (IV)
  • 28 Nov 2002 A study has been added to the Obstructive Airways Disease therapeutic trials section
  • 03 Mar 2000 Launched for Acute heart failure (Treatment-experienced) in Japan (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top